<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01787591</url>
  </required_header>
  <id_info>
    <org_study_id>2012H0344</org_study_id>
    <nct_id>NCT01787591</nct_id>
  </id_info>
  <brief_title>Dairy Fat as a Mediator of Vitamin E Adequacy in Individuals With Metabolic Syndrome</brief_title>
  <official_title>Dairy Fat as a Mediator of Vitamin E Adequacy in Individuals With Metabolic Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ohio State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ohio State University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is conducted to investigate if vitamin E status in healthy individuals and
      individuals with metabolic syndrome can be improved by dairy fat. The investigators
      hypothesize that full-fat dairy will substantially increase the bioavailability of
      alpha-tocopherol, a form of vitamin E. The results of this study will contribute to the
      application of dairy fat as a simple and effective strategy for improving vitamin E status,
      which is partly due to poor vitamin E intake. By completing this study, the investigators
      anticipate developing new dietary recommendations to achieve adequate vitamin E status
      through the regular consumption of dairy fat paired with foods containing vitamin E.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Nonalcoholic steatohepatitis (NASH) is the hepatic manifestation of metabolic syndrome and
      affects &gt;70 million Americans. Weight loss and vitamin E supplementation are leading
      strategies for preventing and/or treating NASH. However, the long-term success of weight loss
      is limited and &gt;92% of Americans fail to meet dietary recommendations for vitamin E. Thus,
      the objective is to define the extent to which dairy fat facilitates adequate vitamin E
      status in individuals with metabolic syndrome, a population at high-risk for NASH, by
      improving α-tocopherol bioavailability. The central hypothesis is that full-fat dairy will
      substantially increase alpha-tocopherol (a-T) bioavailability to the extent needed to
      facilitate production of alpha-carboxyethyl-hydroxy-chromanol (a-CEHC), a metabolite of a-T
      that predict a-T status. The will therefore complete the following specific aims: 1) define
      milk fat-mediated improvements in a-T bioavailability, and 2) define dairy fat-mediated
      improvements in a-T status. This study involves a randomized crossover study design where
      healthy adults and those with metabolic syndrome (n = 10/group) will ingest deuterium-labeled
      a-T (15 mg) with 1 cup of either fat-free milk, low-fat milk, whole milk, or soy milk. Urine
      and blood samples will be collected at timed intervals prior to and following milk
      consumption. Blood will be collected at timed intervals over 72 h, and plasma will be
      analyzed by liquid chromatography with mass spectrometry to determine pharmacokinetic
      parameters by measuring labeled and unlabeled a-T and a-CEHC. Risk to participants is
      expected to be minimal and will be outlined in the informed consent form in clear and simple
      terms. Upon successful completion of this study, it is expected to show that a-T
      bioavailability increases in a milk fat-dependent manner and that dairy milk compared with
      soy milk significantly improves a-T bioavailability. The results are expected to provide
      timely evidence demonstrating the amount and type of fat needed to achieve optimal vitamin E
      status specifically in a population of significant public health concern. Overall, these
      studies will fill a substantial knowledge gap regarding the importance of dairy fat in
      contributing to optimal health and provide a simple dietary approach to ameliorate poor
      vitamin E status among a significant proportion of Americans.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Area Under the Curve 0-72 h (Deuterium Labeled Alpha-tocopherol)</measure>
    <time_frame>0, 3, 6, 9, 12, 24, 36, 48, and 72 h post test meal</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cmax</measure>
    <time_frame>0-72 h post-meal</time_frame>
    <description>Maximal plasma concentration of deuterium labelled alpha-tocopherol</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tmax</measure>
    <time_frame>0-72 h post-meal</time_frame>
    <description>Time to maximal plasma concentration of deuterium labelled alpha-tocopherol</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Elimination Rate</measure>
    <time_frame>0-72 h post-meal</time_frame>
    <description>Rate of plasma elimination of deuterium labelled alpha-tocopherol</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Estimated Absorption (% Dose)</measure>
    <time_frame>0-72 h post-meal</time_frame>
    <description>Absorption of deuterium labelled alpha-tocopherol</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Non-alcoholic Fatty Liver</condition>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>Acute Fat-Free Milk Ingestion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will ingest 1 cup of fat-free milk with 15 mg deuterium-labeled alpha-tocopherol.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acute Low-Fat Milk Ingestion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will ingest 1 cup of low-fat milk with 15 mg deuterium-labeled alpha-tocopherol.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acute Full-Fat Milk Ingestion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will ingest 1 cup of full-fat milk with 15 mg deuterium-labeled alpha-tocopherol.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acute Soy Milk Ingestion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will ingest 1 cup of soy milk with 15 mg deuterium-labeled alpha-tocopherol.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fat-Free Milk</intervention_name>
    <description>Fat-free milk ingestion with 15 mg deuterium-labeled alpha-tocopherol.</description>
    <arm_group_label>Acute Fat-Free Milk Ingestion</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Low-Fat Milk</intervention_name>
    <description>Low-fat milk ingestion with 15 mg deuterium-labeled alpha-tocopherol.</description>
    <arm_group_label>Acute Low-Fat Milk Ingestion</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Full-Fat Milk</intervention_name>
    <description>Full-fat milk ingestion with 15 mg deuterium-labeled alpha-tocopherol.</description>
    <arm_group_label>Acute Full-Fat Milk Ingestion</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Soy Milk</intervention_name>
    <description>Soy milk ingestion with 15 mg deuterium-labeled alpha-tocopherol.</description>
    <arm_group_label>Acute Soy Milk Ingestion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  specific criteria of the metabolic syndrome: large waist circumference (&gt;102 or &gt;89 cm
             for men and women, respectively), high fasting triglycerides (150-300 mg/dL), low
             fasting HDL (&lt;40 and &lt;50 mg/dL for men and women, respectively), high blood pressure
             (&gt;130/85 mm Hg) and high fasting glucose (110-180 mg/dL)

          -  BMI: &gt;30 kg/m2,

          -  non-dietary supplement users for &gt;2-mo

          -  no use of medications known to affect lipid metabolism

          -  no history of gastrointestinal disorders

          -  resting blood pressure &lt;140 mm Hg

          -  not taking any medications that control hypertension

        Exclusion Criteria:

          -  lactose-intolerance

          -  excessive alcohol consumption (&gt;3 drinks/d)

          -  &gt;5 h/wk of aerobic activity

          -  women who are pregnant, lactating, or have initiated or changed birth control in the
             past 3-mo

          -  plasma alpha-tocopherol &gt;20 μmol/L.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard Bruno, PhD, RD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ohio State University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Mah E, Sapper TN, Chitchumroonchokchai C, Failla ML, Schill KE, Clinton SK, Bobe G, Traber MG, Bruno RS. α-Tocopherol bioavailability is lower in adults with metabolic syndrome regardless of dairy fat co-ingestion: a randomized, double-blind, crossover trial. Am J Clin Nutr. 2015 Nov;102(5):1070-80. doi: 10.3945/ajcn.115.118570. Epub 2015 Oct 7.</citation>
    <PMID>26447154</PMID>
  </results_reference>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 6, 2013</study_first_submitted>
  <study_first_submitted_qc>February 6, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 8, 2013</study_first_posted>
  <results_first_submitted>March 24, 2016</results_first_submitted>
  <results_first_submitted_qc>September 30, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 22, 2016</results_first_posted>
  <last_update_submitted>September 30, 2016</last_update_submitted>
  <last_update_submitted_qc>September 30, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ohio State University</investigator_affiliation>
    <investigator_full_name>Richard Bruno</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Vitamin E</keyword>
  <keyword>Metabolic syndrome</keyword>
  <keyword>Liver disease</keyword>
  <keyword>Non-alcoholic liver steatohepatitis</keyword>
  <keyword>Fatty liver</keyword>
  <keyword>Dairy consumption</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
    <mesh_term>Fatty Liver</mesh_term>
    <mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin E</mesh_term>
    <mesh_term>Tocopherols</mesh_term>
    <mesh_term>Tocotrienols</mesh_term>
    <mesh_term>alpha-Tocopherol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data will be shared when it becomes available</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Acute Fat-Free Milk Ingestion First</title>
          <description>Participants ingested fat-free milk first and then the remaining three milks in a randomized order: low-fat milk, full-fat milk, and soy milk.
Participants will ingest 1 cup of fat-free milk with 15 mg deuterium-labeled alpha-tocopherol.
Fat-Free Milk: Fat-free milk ingestion with 15 mg deuterium-labeled alpha-tocopherol.</description>
        </group>
        <group group_id="P2">
          <title>Acute Low-Fat Milk Ingestion First</title>
          <description>Participants ingested low-free milk first and then the remaining three milks in a randomized order: fat-fat milk, full-fat milk, and soy milk.
Participants will ingest 1 cup of low-fat milk with 15 mg deuterium-labeled alpha-tocopherol.
Low-Fat Milk: Low-fat milk ingestion with 15 mg deuterium-labeled alpha-tocopherol.</description>
        </group>
        <group group_id="P3">
          <title>Acute Full-Fat Milk Ingestion First</title>
          <description>Participants ingested full-free milk first and then the remaining three milks in a randomized order: low-fat milk, low-fat milk, and soy milk.
Participants will ingest 1 cup of full-fat milk with 15 mg deuterium-labeled alpha-tocopherol.
Full-Fat Milk: Full-fat milk ingestion with 15 mg deuterium-labeled alpha-tocopherol.</description>
        </group>
        <group group_id="P4">
          <title>Acute Soy Milk Ingestion First</title>
          <description>Participants ingested soy milk first and then the remaining three milks in a randomized order: low-fat milk, full-fat milk, and fat-free milk.
Participants will ingest 1 cup of soy milk with 15 mg deuterium-labeled alpha-tocopherol.
Soy Milk: Soy milk ingestion with 15 mg deuterium-labeled alpha-tocopherol.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Period 1 (Cross-over Arm 1)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="5"/>
                <participants group_id="P4" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="5"/>
                <participants group_id="P4" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Period 2 (Cross-over Arm 2)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="5"/>
                <participants group_id="P4" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="5"/>
                <participants group_id="P4" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Period 3 (Cross-over Arm 3)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="5"/>
                <participants group_id="P4" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="5"/>
                <participants group_id="P4" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Period 4 (Cross-over Arm 4)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="5"/>
                <participants group_id="P4" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="5"/>
                <participants group_id="P4" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Healthy Participants</title>
          <description>As a randomized crossover study design, participants were stratified by health status (healthy versus metabolic syndrome) and received fat-free milk, low-fat milk, full-fat milk, and soy milk in a randomized order.</description>
        </group>
        <group group_id="B2">
          <title>Metabolic Syndrome Participants</title>
          <description>As a randomized crossover study design, participants were stratified by health status (healthy versus metabolic syndrome) and received fat-free milk, low-fat milk, full-fat milk, and soy milk in a randomized order.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
            <count group_id="B2" value="10"/>
            <count group_id="B3" value="20"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30.3" spread="4"/>
                    <measurement group_id="B2" value="32.8" spread="5.1"/>
                    <measurement group_id="B3" value="31.6" spread="4.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body mass index</title>
          <units>kg/m2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22.6" spread="2.2"/>
                    <measurement group_id="B2" value="37.7" spread="9.4"/>
                    <measurement group_id="B3" value="30.2" spread="10.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Glucose</title>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="89.2" spread="6.2"/>
                    <measurement group_id="B2" value="107.6" spread="4.2"/>
                    <measurement group_id="B3" value="98.4" spread="13.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Systolic Blood Pressure</title>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="118.8" spread="9.5"/>
                    <measurement group_id="B2" value="128.2" spread="23.6"/>
                    <measurement group_id="B3" value="123.5" spread="18.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diastolic Blood Pressure</title>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="74.0" spread="7.9"/>
                    <measurement group_id="B2" value="79.0" spread="10.1"/>
                    <measurement group_id="B3" value="76.5" spread="9.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Waist Circumference</title>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="75.2" spread="6.5"/>
                    <measurement group_id="B2" value="116.1" spread="23.7"/>
                    <measurement group_id="B3" value="95.7" spread="27.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Triglyceride</title>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="82.0" spread="30.4"/>
                    <measurement group_id="B2" value="152.7" spread="68.1"/>
                    <measurement group_id="B3" value="117.4" spread="62.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>HDL cholesterol</title>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56.0" spread="9.9"/>
                    <measurement group_id="B2" value="41.2" spread="10.8"/>
                    <measurement group_id="B3" value="48.6" spread="12.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>alpha-tocopherol</title>
          <units>umol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22.2" spread="3.9"/>
                    <measurement group_id="B2" value="23.9" spread="2.8"/>
                    <measurement group_id="B3" value="23.1" spread="3.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>alpha-tocopherol</title>
          <units>umol/mmol lipid</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4.54" spread="0.85"/>
                    <measurement group_id="B2" value="3.71" spread="0.85"/>
                    <measurement group_id="B3" value="4.13" spread="0.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Area Under the Curve 0-72 h (Deuterium Labeled Alpha-tocopherol)</title>
        <time_frame>0, 3, 6, 9, 12, 24, 36, 48, and 72 h post test meal</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Acute Fat-Free Milk Ingestion</title>
            <description>Participants will ingest 1 cup of fat-free milk with 15 mg deuterium-labeled alpha-tocopherol.
Fat-Free Milk: Fat-free milk ingestion with 15 mg deuterium-labeled alpha-tocopherol.</description>
          </group>
          <group group_id="O2">
            <title>Acute Low-Fat Milk Ingestion</title>
            <description>Participants will ingest 1 cup of low-fat milk with 15 mg deuterium-labeled alpha-tocopherol.
Low-Fat Milk: Low-fat milk ingestion with 15 mg deuterium-labeled alpha-tocopherol.</description>
          </group>
          <group group_id="O3">
            <title>Acute Full-Fat Milk Ingestion</title>
            <description>Participants will ingest 1 cup of full-fat milk with 15 mg deuterium-labeled alpha-tocopherol.
Full-Fat Milk: Full-fat milk ingestion with 15 mg deuterium-labeled alpha-tocopherol.</description>
          </group>
          <group group_id="O4">
            <title>Acute Soy Milk Ingestion</title>
            <description>Participants received 1 cup of soy milk with deuterium labeled alpha-tocopherol</description>
          </group>
        </group_list>
        <measure>
          <title>Area Under the Curve 0-72 h (Deuterium Labeled Alpha-tocopherol)</title>
          <units>umol/L x h</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Healthy Participants</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="103" spread="7"/>
                    <measurement group_id="O2" value="115" spread="8"/>
                    <measurement group_id="O3" value="102" spread="8"/>
                    <measurement group_id="O4" value="102" spread="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Metabolic Syndrome Participants</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86" spread="8"/>
                    <measurement group_id="O2" value="84" spread="7"/>
                    <measurement group_id="O3" value="81" spread="7"/>
                    <measurement group_id="O4" value="74" spread="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Cmax</title>
        <description>Maximal plasma concentration of deuterium labelled alpha-tocopherol</description>
        <time_frame>0-72 h post-meal</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Acute Fat-Free Milk Ingestion</title>
            <description>Participants will ingest 1 cup of fat-free milk with 15 mg deuterium-labeled alpha-tocopherol.
Fat-Free Milk: Fat-free milk ingestion with 15 mg deuterium-labeled alpha-tocopherol.</description>
          </group>
          <group group_id="O2">
            <title>Acute Low-Fat Milk Ingestion</title>
            <description>Participants will ingest 1 cup of low-fat milk with 15 mg deuterium-labeled alpha-tocopherol.
Low-Fat Milk: Low-fat milk ingestion with 15 mg deuterium-labeled alpha-tocopherol.</description>
          </group>
          <group group_id="O3">
            <title>Acute Full-Fat Milk Ingestion</title>
            <description>Participants will ingest 1 cup of full-fat milk with 15 mg deuterium-labeled alpha-tocopherol.
Full-Fat Milk: Full-fat milk ingestion with 15 mg deuterium-labeled alpha-tocopherol.</description>
          </group>
          <group group_id="O4">
            <title>Acute Soy Milk Ingestion</title>
            <description>Participants ingested 1 cup of soy milk with deuterium labeled alpha-tocopherol</description>
          </group>
        </group_list>
        <measure>
          <title>Cmax</title>
          <description>Maximal plasma concentration of deuterium labelled alpha-tocopherol</description>
          <units>umol/L</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Healthy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.67" spread="0.2"/>
                    <measurement group_id="O2" value="2.98" spread="0.18"/>
                    <measurement group_id="O3" value="2.55" spread="0.21"/>
                    <measurement group_id="O4" value="2.67" spread="0.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Metabolic Syndrome</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.14" spread="0.2"/>
                    <measurement group_id="O2" value="2.01" spread="0.19"/>
                    <measurement group_id="O3" value="1.98" spread="0.16"/>
                    <measurement group_id="O4" value="1.88" spread="0.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Tmax</title>
        <description>Time to maximal plasma concentration of deuterium labelled alpha-tocopherol</description>
        <time_frame>0-72 h post-meal</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Acute Fat-Free Milk Ingestion</title>
            <description>Participants will ingest 1 cup of fat-free milk with 15 mg deuterium-labeled alpha-tocopherol.
Fat-Free Milk: Fat-free milk ingestion with 15 mg deuterium-labeled alpha-tocopherol.</description>
          </group>
          <group group_id="O2">
            <title>Acute Low-Fat Milk Ingestion</title>
            <description>Participants will ingest 1 cup of low-fat milk with 15 mg deuterium-labeled alpha-tocopherol.
Low-Fat Milk: Low-fat milk ingestion with 15 mg deuterium-labeled alpha-tocopherol.</description>
          </group>
          <group group_id="O3">
            <title>Acute Full-Fat Milk Ingestion</title>
            <description>Participants will ingest 1 cup of full-fat milk with 15 mg deuterium-labeled alpha-tocopherol.
Full-Fat Milk: Full-fat milk ingestion with 15 mg deuterium-labeled alpha-tocopherol.</description>
          </group>
          <group group_id="O4">
            <title>Acute Soy Milk Ingestion</title>
            <description>Participants ingested 1 cup of soy milk with deuterium labeled alpha-tocopherol</description>
          </group>
        </group_list>
        <measure>
          <title>Tmax</title>
          <description>Time to maximal plasma concentration of deuterium labelled alpha-tocopherol</description>
          <units>h</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Healthy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12" spread="0"/>
                    <measurement group_id="O2" value="12" spread="0"/>
                    <measurement group_id="O3" value="13.2" spread="1.2"/>
                    <measurement group_id="O4" value="12" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Metabolic Syndrome</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12" spread="0"/>
                    <measurement group_id="O2" value="12" spread="0"/>
                    <measurement group_id="O3" value="12" spread="0"/>
                    <measurement group_id="O4" value="12" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Elimination Rate</title>
        <description>Rate of plasma elimination of deuterium labelled alpha-tocopherol</description>
        <time_frame>0-72 h post-meal</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Acute Fat-Free Milk Ingestion</title>
            <description>Participants will ingest 1 cup of fat-free milk with 15 mg deuterium-labeled alpha-tocopherol.
Fat-Free Milk: Fat-free milk ingestion with 15 mg deuterium-labeled alpha-tocopherol.</description>
          </group>
          <group group_id="O2">
            <title>Acute Low-Fat Milk Ingestion</title>
            <description>Participants will ingest 1 cup of low-fat milk with 15 mg deuterium-labeled alpha-tocopherol.
Low-Fat Milk: Low-fat milk ingestion with 15 mg deuterium-labeled alpha-tocopherol.</description>
          </group>
          <group group_id="O3">
            <title>Acute Full-Fat Milk Ingestion</title>
            <description>Participants will ingest 1 cup of full-fat milk with 15 mg deuterium-labeled alpha-tocopherol.
Full-Fat Milk: Full-fat milk ingestion with 15 mg deuterium-labeled alpha-tocopherol.</description>
          </group>
          <group group_id="O4">
            <title>Acute Soy Milk Ingestion</title>
            <description>Participants ingested 1 cup of soy milk with deuterium labeled alpha-tocopherol</description>
          </group>
        </group_list>
        <measure>
          <title>Elimination Rate</title>
          <description>Rate of plasma elimination of deuterium labelled alpha-tocopherol</description>
          <units>mmol/L/h</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Healthy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.022" spread="0.001"/>
                    <measurement group_id="O2" value="0.024" spread="0.001"/>
                    <measurement group_id="O3" value="0.023" spread="0.001"/>
                    <measurement group_id="O4" value="0.023" spread="0.001"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Metabolic Syndrome</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.019" spread="0.001"/>
                    <measurement group_id="O2" value="0.020" spread="0.001"/>
                    <measurement group_id="O3" value="0.021" spread="0.001"/>
                    <measurement group_id="O4" value="0.022" spread="0.001"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Estimated Absorption (% Dose)</title>
        <description>Absorption of deuterium labelled alpha-tocopherol</description>
        <time_frame>0-72 h post-meal</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Acute Fat-Free Milk Ingestion</title>
            <description>Participants will ingest 1 cup of fat-free milk with 15 mg deuterium-labeled alpha-tocopherol.
Fat-Free Milk: Fat-free milk ingestion with 15 mg deuterium-labeled alpha-tocopherol.</description>
          </group>
          <group group_id="O2">
            <title>Acute Low-Fat Milk Ingestion</title>
            <description>Participants will ingest 1 cup of low-fat milk with 15 mg deuterium-labeled alpha-tocopherol.
Low-Fat Milk: Low-fat milk ingestion with 15 mg deuterium-labeled alpha-tocopherol.</description>
          </group>
          <group group_id="O3">
            <title>Acute Full-Fat Milk Ingestion</title>
            <description>Participants will ingest 1 cup of full-fat milk with 15 mg deuterium-labeled alpha-tocopherol.
Full-Fat Milk: Full-fat milk ingestion with 15 mg deuterium-labeled alpha-tocopherol.</description>
          </group>
          <group group_id="O4">
            <title>Acute Soy Milk Ingestion</title>
            <description>Participants ingested 1 cup of soy milk with deuterium labeled alpha-tocopherol</description>
          </group>
        </group_list>
        <measure>
          <title>Estimated Absorption (% Dose)</title>
          <description>Absorption of deuterium labelled alpha-tocopherol</description>
          <units>% dose</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Healthy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.8" spread="1.4"/>
                    <measurement group_id="O2" value="32.4" spread="1.6"/>
                    <measurement group_id="O3" value="28.4" spread="1.3"/>
                    <measurement group_id="O4" value="28.1" spread="0.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Metabolic Syndrome</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.6" spread="1.8"/>
                    <measurement group_id="O2" value="26.0" spread="2.5"/>
                    <measurement group_id="O3" value="25.6" spread="1.9"/>
                    <measurement group_id="O4" value="24.62" spread="2.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Acute Fat-Free Milk Ingestion</title>
          <description>Participants will ingest 1 cup of fat-free milk with 15 mg deuterium-labeled alpha-tocopherol.
Fat-Free Milk: Fat-free milk ingestion with 15 mg deuterium-labeled alpha-tocopherol.</description>
        </group>
        <group group_id="E2">
          <title>Acute Low-Fat Milk Ingestion</title>
          <description>Participants will ingest 1 cup of low-fat milk with 15 mg deuterium-labeled alpha-tocopherol.
Low-Fat Milk: Low-fat milk ingestion with 15 mg deuterium-labeled alpha-tocopherol.</description>
        </group>
        <group group_id="E3">
          <title>Acute Full-Fat Milk Ingestion</title>
          <description>Participants will ingest 1 cup of full-fat milk with 15 mg deuterium-labeled alpha-tocopherol.
Full-Fat Milk: Full-fat milk ingestion with 15 mg deuterium-labeled alpha-tocopherol.</description>
        </group>
        <group group_id="E4">
          <title>Acute Soy Milk Ingestion</title>
          <description>Participants will ingest 1 cup of soy milk with 15 mg deuterium-labeled alpha-tocopherol.
Soy Milk: Soy milk ingestion with 15 mg deuterium-labeled alpha-tocopherol.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Richard S. Bruno, PhD, RD</name_or_title>
      <organization>The Ohio State University</organization>
      <phone>614-292-1698</phone>
      <email>bruno.27@osu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

